Real-world activity of sacituzumab govitecan for metastatic breast cancer

被引:0
|
作者
Morganti, S. [1 ]
Kusmick, R. [1 ]
Hughes, M. E. [1 ]
Braso-Maristany, F. [2 ]
Smith, K. [1 ]
Tarantino, P. [1 ]
Vega Leon, M. D. R. [3 ]
Grinda, T. [1 ]
Pardo, F. [4 ]
Dvir, K. [1 ]
Suggs, G. [1 ]
Buck, S. [1 ]
Skeffington, M. [1 ]
Garrido-Castro, A. C. [1 ]
Parsons, H. [1 ]
Sammons, S. [1 ]
Prat, A. [5 ]
Lin, N. [1 ]
Tolaney, S. M. [1 ]
Giordano, A. [1 ]
机构
[1] Dana Farber Canc Inst, Breast Oncol Ctr, Boston, MA USA
[2] Inst Invest Biomed August Pi & Sunyer, Dept Oncol, IDIBAPS Fundacio Recerca Clin Barcelona, Barcelona, Spain
[3] VHIO Vall dHebron Inst Oncol, Genom Dept, Barcelona, Spain
[4] Reveal Genom SL, Barcelona, Spain
[5] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain
关键词
D O I
10.1016/j.annonc.2024.08.339
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
391P
引用
收藏
页码:S382 / S382
页数:1
相关论文
共 50 条
  • [1] Real-world outcomes of sacituzumab govitecan in breast cancer
    Singh, Vaishnavi
    Dhaibar, Hemangini
    Peddi, Prakash
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Sacituzumab Govitecan in Metastatic Breast Cancer
    Ganguly, Shuvadeep
    Gogia, Ajay
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03):
  • [3] SACITUZUMAB GOVITECAN - REAL-WORLD EXPERIENCE OF A PORTUGUESE CANCER CENTER
    Cabral, Sara
    Pereira, Carolina
    Cardoso, Catarina
    Gouveia, Emanuel
    Nunes, Hugo
    Pereira, Patricia
    Brito, Margarida
    BREAST, 2023, 71 : S61 - S61
  • [4] Sacituzumab-govitecan in metastatic breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (01) : 16 - 16
  • [5] Sacituzumab Govitecan in Metastatic Breast Cancer REPLY
    Bardia, Aditya
    Hurvitz, Sara A.
    Rugo, Hope S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03):
  • [6] Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom
    Hanna, Daire
    Merrick, Sophie
    Ghose, Aruni
    Devlin, Michael John
    Yang, Dorothy D.
    Phillips, Edward
    Okines, Alicia
    Chopra, Neha
    Papadimatraki, Elisavet
    Ross, Kirsty
    Macpherson, Iain
    Boh, Zhuang Y.
    Michie, Caroline O.
    Swampillai, Angela
    Gupta, Sunnia
    Robinson, Tim
    Germain, Lewis
    Twelves, Chris
    Atkinson, Charlotte
    Konstantis, Apostolos
    Riddle, Pippa
    Cresti, Nicola
    Naik, Jay D.
    Borley, Annabel
    Guppy, Amy
    Schmid, Peter
    Phillips, Melissa
    BRITISH JOURNAL OF CANCER, 2024, 130 (12) : 1916 - 1920
  • [7] Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases
    Grinda, Thomas
    Morganti, Stefania
    Hsu, Liangge
    Yoo, Tae-Kyung
    Kusmick, Ross J.
    Aizer, Ayal A.
    Giordano, Antonio
    Leone, Jose P.
    Hughes, Melissa
    Tolaney, Sara M.
    Lin, Nancy U.
    Sammons, Sarah L.
    NPJ BREAST CANCER, 2025, 11 (01)
  • [8] Sacituzumab govitecan activity in advanced breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2017, 18 (05): : E246 - E246
  • [9] The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patientsda multicenter real-world analysis
    Dannehl, D.
    Jakob, D.
    Mergel, F.
    Estler, A.
    Engler, T.
    Volmer, L.
    Frevert, M-L
    Matovina, S.
    Englisch, A.
    Tegeler, C. M.
    Rohner, A.
    Seller, A.
    Hahn, M.
    Pfister, K.
    Fink, A.
    Popp, I.
    Lorenz, S.
    Tabatabai, G.
    Juhasz-Boess, I.
    Janni, W.
    Brucker, S.
    Taran, F. -A
    Hartkopf, A.
    Schaeffler, H.
    ESMO OPEN, 2024, 9 (05)
  • [10] SARELIFE: An Italian, multicentric real-world study of sacituzumab govitecan (SG) in pretreated metastatic triple-negative breast cancer (mTNBC)
    Cona, M. S.
    Ruggieri, L.
    Artale, S. A. A.
    Catania, G.
    D'Auria, G.
    Gallerani, E.
    Villa, F.
    Gambaro, A.
    Chirco, A.
    Giordano, M.
    Pistelli, M.
    Verderame, F.
    Bramati, A.
    Stani, S. C.
    Vici, P.
    Meattini, I.
    Tagliaferri, B.
    Tedesco, B.
    Amato, O.
    La Verde, N. M.
    ANNALS OF ONCOLOGY, 2024, 35 : S381 - S382